The GLP-1 Revolution: How a Diabetes Drug Became the Fastest-Growing Drug Category in Medicare History

Medicare Part D spending on GLP-1 drugs grew from $2.3 billion in 2019 to roughly $27 billion by 2024. This post traces that explosion through CMS spending data, beneficiary counts, state-level adopti...